Status: current, Defined. Date: 31-Dec 2010. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 948689011000036110 | Claratyne-D with Decongestant Repetab (loratadine 5 mg + pseudoephedrine sulfate 120 mg) modified release tablet, 6 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 948691011000036110 | Claratyne-D with Decongestant Repetab modified release tablet, 6 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Claratyne-D with Decongestant Repetab modified release tablet, 6 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Claratyne-D with Decongestant Repetab modified release tablet, 6 | Is a | loratadine 5 mg + pseudoephedrine sulfate 120 mg modified release tablet, 6 | true | Inferred relationship | Some | ||
| Claratyne-D with Decongestant Repetab modified release tablet, 6 | has TPUU | Claratyne-D with Decongestant Repetab modified release tablet | true | Inferred relationship | Some | 1 | |
| Claratyne-D with Decongestant Repetab modified release tablet, 6 | has TP | Claratyne-D with Decongestant Repetab | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Claratyne-D with Decongestant Repetab modified release tablet, 6, blister pack | Is a | True | Claratyne-D with Decongestant Repetab modified release tablet, 6 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR